This compound is a specialized pharmaceutical intermediate used in the synthesis of complex organic molecules. Its structure features multiple aromatic rings, ether linkages, and key functional groups such as an alcohol and an amide, indicating a role in advanced chemical manufacturing.
Portée du contenu: Les informations de cette page concernent l'identification chimique ainsi que les contextes d'approvisionnement industriel, de recherche et de production. Elles ne constituent ni une allégation thérapeutique, ni un avis médical, ni une notice d'utilisation médicamenteuse.
Approvisionnement ou fourniture de ce composé?
Publiez votre inventaire ou une demande d'achat
CAS 251647-48-0
N-(9-((2R,3R,4R,5R)-5-((Bis(4-methoxyphenyl)(phenyl)methoxy)methyl)-4-hydroxy-3-methoxytetrahydrofuran-2-yl)-9H-purin-6-yl)benzamide
nucleoside intermediate for oligonucleotide synthesis
N-Benzoyl-5'-O-(bis(4-methoxyphenyl)(phenyl)methyl)-2'-O-(tert-butyl(dimethyl)silyl)adenosine
nucleoside phosphoramidite building block
DMT-2'-F-Bz-dA
modified nucleoside research reagent
Adenosine, N-benzoyl-2'-O-(2-methoxyethyl)-
Pharmaceutical intermediate for nucleoside analogs
5'-O-[Bis(4-methoxyphenyl)phenylmethyl]-2'-O-(2-methoxyethyl)-N-(2-methyl-1-oxopropyl)guanosine
nucleoside analog pharmaceutical intermediate
2'-O-MOE-N6-Benzoyl-Adenosine Phosphoramidite
nucleoside phosphoramidite building block
Guanosine, 5'-O-[bis(4-methoxyphenyl)phenylmethyl]-2'-O-(2-methoxyethyl)-N-(2-methyl-1-oxopropyl)-, 3'-[2-cyanoethyl N,N-bis(1-methylethyl)phosphoramidite]
protected nucleoside phosphoramidite building block
Azetidinecarboxylic acid
proline analog for research
N-[9-[(2R,3R,4R,5R)-5-[[bis(4-methoxyphenyl)-phenylmethoxy]methyl]-4-hydroxy-3-(2-methoxyethoxy)oxolan-2-yl]purin-6-yl]benzamide
KEVMXGNDTKPSMC-MUMPVVMASA-N
COCCO[C@@H]1[C@@H]([C@H](O[C@H]1N2C=NC3=C(N=CN=C32)NC(=O)C4=CC=CC=C4)COC(C5=CC=CC=C5)(C6=CC=C(C=C6)OC)C7=CC=C(C=C7)OC)O
—